TMCnet - World's Largest Communications and Technology Community



Intellicheck Announces Third Quarter 2017 Financial Results
[November 14, 2017]

Intellicheck Announces Third Quarter 2017 Financial Results

Intellicheck, Inc. (NYSE American: IDN), an industry leader in delivering real-time threat identification and identification authentication that provides the antivirus to the epidemic of counterfeit IDs, today announced its financial results for the third quarter ended September 30, 2017.

Revenue for the third quarter ended September 30, 2017 decreased 20% to $967,000 compared to $1,214,000 for the quarter ended September 30, 2016. SaaS revenue increased 73% to $520,000 for the third quarter, compared to approximately $300,000 during the second quarter of 2017. Gross profit as a percentage of revenues increased to 89.1% for the three months ended September 30, 2017 compared to 77.1% for the three months ended September 30, 2016. The Company's booked orders for the third quarter decreased 20% to approximately $931,000 compared to $1,169,000 during the prior year comparable quarter.

Operating expenses, which consist of selling, general and administrative, and research and development expenses, increased by approximately 16% or $267,000 to $1,944,000 for the three months ended September 30, 2017 from $1,677,000 in the comparable prior year period. The net loss for the three months ended September 30, 2017 was $1,075,000 or $0.08 per diluted share compared to a net loss of $727,000 or $0.07 per diluted share for the comparable prior year period.

Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization, stock-based compensation expense and certain non-recurring charges) for the quarter ended September 30, 2017 was a loss of $888,000 compared to an Adjusted EBITDA loss of $490,000 for the third quarter of 2016. A reconciliation of net loss to Adjusted EBITDA is provided elsewhere in this release.

"We are pleased with the sequential increase in our SaaS revenues and we are confident that we have the right products at the right time that will allow us to continue to execute our plans for future growth," stated Intellicheck Interim CEO Bill White. "We are excited about the prospects ahead of us at a time when we see several important indicators that point to what we believe will be strong growth in product adoption in key markets. Although it has taken longer than we anticipated, we have demonstrated our software's efficacy in the numerous market verticals we serve."

"Additionally," White concluded, "we have some significant patents in the biometric space that we look forward to seeing through to commercialization as we pursue our vision for innovative product development that we believe will allow us to remain competitive as technology evolves."

The unaudited financial results reported today do not take into account any adjustments that may be required in connection with the completion of the Company's review process and should be considered preliminary until Intellicheck files its Form 10-Q for the fiscal quarter ended September 30, 2017.

September 30, December 31,
2017   2016  
Cash $ 8,940,762 $ 3,092,172

Accounts receivable, net of allowance of $18,750 and $74,354 as of September 30, 2017 and December 31, 2016, respectively

725,562 502,126
Inventory 81,591 70,547
Other current assets 312,977   165,473  
Total current assets 10,060,892 3,830,318
NOTE RECEIVABLE, net of current portion 81,407 114,909
PROPERTY AND EQUIPMENT, net 211,256 270,776
GOODWILL 8,101,661 8,101,661
INTANGIBLE ASSETS, net 1,917,890 2,154,563
OTHER ASSETS 59,940   61,298  
Total assets $ 20,433,046   $ 14,533,525  
Accounts payable $ 98,433 $ 14,140
Accrued expenses 692,006 519,957
Deferred revenue, current portion 706,972   825,538  
Total current liabilities 1,497,411 1,359,635
Deferred revenue, long-term portion 100,348 177,306
Deferred rent -   61,133  
Total liabilities 1,597,759 1,598,074

Common stock - $.001 par value; 40,000,000 shares authorized; 14,981,633 and 10,718,553 shares issued and outstanding, respectively

14,982 10,719
Additional paid-in capital 126,332,780 117,293,158
Accumulated deficit (107,512,475 ) (104,368,426 )
Total stockholders' equity 18,835,287   12,935,451  
Total liabilities and stockholders' equity $ 20,433,046   $ 14,533,525  



Three Months Ended September 30, Nine Months Ended September 30,







REVENUES $ 966,690 $ 1,214,308 $ 2,630,684 $ 3,105,330
COST OF REVENUES (105,013 ) (268,137 ) (419,083 ) (622,833 )
Gross profit 861,677 946,171 2,211,601 2,482,497
Selling, general and administrative 1,459,234 1,268,915 3,984,478 5,115,838
Research and development 484,970   407,615   1,350,615   2,024,818  
Total operating expenses 1,944,204   1,676,530   5,335,093   7,140,656  
Loss from operations (1,082,527 ) (730,359 ) (3,123,492 ) (4,658,159 )
Interest and other income 7,682   3,437   13,337   12,630  
Net loss $ (1,074,845 ) $ (726,922 ) $ (3,110,155 ) $ (4,645,529 )
Loss per common share -
Basic/Diluted $ (0.08 ) $ ( 0.07 ) $ (0.27 ) $ ( 0.48 )

Weighted average common shares used in computing per share amounts -

Basic/Diluted 13,167,955   10,246,629   11,565,340   9,680,010  

For the nine months ended September 30, 2017


      Additional     Total

Common Stock

Paid-in Accumulated Stockholders'






BALANCE, January 1, 2017 10,718,553 $ 10,719 $ 117,293,158 $ (104,368,426 ) $ 12,935,451
Cumulative adjustment upon modified retrospective adoption of ASU 2016-09 - - 33,894   (33,894 ) -  
Balance after adoption of recent accounting pronouncement 10,718,553 10,719 117,327,052 (104,402,320 ) 12,935,451
Stock-based compensation expense - - 282,330 - 282,330
Issuance of common stock, net of costs 4,168,750 4,169 8,573,692 - 8,577,861
Exercise of stock options 10,000 10 10,090 - 10,100
Exercise of warrants 63,500 63 139,637 - 139,700
Vesting of restricted stock 20,830 21 (21 ) - -
Net loss - - -   (3,110,155 ) (3,110,155 )
BALANCE, September 30, 2017 14,981,633 $ 14,982 $ 126,332,780   $ (107,512,475 ) $ 18,835,287  




Nine Months Ended September 30,




Net loss $ (3,110,155 ) $ (4,645,529 )

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization 311,871 328,105
Noncash stock-based compensation expense 282,330 802,623
Provision for doubtful accounts (55,604 ) 12,764
Deferred rent (34,122 ) (27,115 )
Changes in assets and liabilities:
(Increase) decrease in accounts receivable (167,832 ) 318,318
(Increase) decrease in inventory (11,044 ) 491
(Increase) in other current assets (146,193 ) (120,776 )
Decrease (increase) in other assets 1,358 (1,498 )
Increase (decrease) in accounts payable and accrued expenses 229,331 (11,087 )
(Decrease) in deferred revenue (195,524 ) (127,079 )
Net cash used in operating activities (2,895,584 ) (3,470,783 )
Purchases of property and equipment (15,678 ) (50,707 )
Collection of note receivable 32,191   29,020  
Net cash provided by (used in) investing activities 16,513   (21,687 )
Net proceeds from issuance of common stock 8,577,861 1,780,341

Net proceeds from issuance of common stock from exercise of stock options

10,100 389,879

Net proceeds from issuance of common stock from exercise of warrants

139,700 -
Purchase and retirement of common stock -   (1,096,608 )
Net cash provided by financing activities 8,727,661   1,073,612  
Net increase (decrease) in cash 5,848,590 (2,418,858 )
CASH, beginning of period 3,092,172   5,953,257  
CASH, end of period $ 8,940,762   $ 3,534,399  

A reconciliation of GAAP net loss to Non-GAAP Adjusted EBITDA follows:


Three Months Ended
September 30,


Nine Months Ended
September 30,







Net loss $ (1,074,845 ) $ (726,922 ) $ (3,110,155 ) $ (4,645,529 )
Reconciling items:
Interest and other - net (7,682 ) (3,437 ) (13,337 ) (12,630 )
Depreciation and amortization 103,271 104,935 311,871 328,105
Stock-based compensation costs 90,812   134,929   282,330   802,623  
Adjusted EBITDA $ (888,444 ) $ (490,495 ) $ (2,529,291 ) $ (3,527,431 )

Earnings Conference Call Information

The Company will hold an earnings conference call today, November 14, at 4:30 p.m. ET/1:30 p.m. PT to discuss operating results. To listen to the earnings conference call, please dial 877-407-8037. For callers outside the U.S., please dial 201-689-8037.

The conference call will also be webcast simultaneously and can be accessed at by clicking on the link to the webcast.

The webcast will be available for 14 days following the conference call.

About Intellicheck NYSE American: IDN

Intellicheck is the industry leader in technology solutions that are the antivirus to the epidemic of counterfeit IDs providing real-time threat identification and identification authentication. Our technology solutions make it possible for our clients to enhance the safety and awareness of their facilities and people, improve customer service, and increase operational efficiencies. Founded in 1994, Intellicheck has grown to serve dozens of Fortune 500 companies including retail and financial industry clients, police departments, national defense clients at agencies, major seaports, and military bases, and diverse state and federal government agencies. The Company holds 25 patents including many patents pertaining to identification technology. For more information on Intellicheck, visit and follow Intellicheck on Twitter @IntellicheckIDN, on Instagram @IntellicheckIDN, on LinkedIn, on Facebook, on YouTube, and read Intellicheck's latest blog post at

Adjusted EBITDA

Intellicheck uses Adjusted EBITDA as a non-GAAP financial performance measurement. Adjusted EBITDA is calculated by starting with net income (loss) and adding back interest, income taxes, impairments of long-lived assets and goodwill, depreciation, amortization and stock-based compensation expense. Adjusted EBITDA is provided to investors to supplement the results of operations reported in accordance with GAAP. Management believes that Adjusted EBITDA provides an additional tool for investors to use in comparing Intellicheck financial results with other companies that also use Adjusted EBITDA in their communications to investors. By excluding non-cash charges such as impairments of long-lived assets and goodwill, amortization, depreciation and stock-based compensation, as well as non-operating charges for interest and income taxes, investors can evaluate the Company's operations and compare its results on a more consistent basis to the results of other companies. In addition, adjusted EBITDA is one of the primary measures that management uses to monitor and evaluate financial and operating results.

Intellicheck considers Adjusted EBITDA to be an important indicator of the Company's operational strength and performance of its business and a useful measure of the Company's historical operating trends. However, there are significant limitations to the use of Adjusted EBITDA, because it excludes interest income and expense, impairments of long-lived assets and goodwill, and stock based compensation expense, all of which impact the Company's profitability, as well as depreciation and amortization related to the use of long-term assets, which benefit multiple periods. Intellicheck believes that these limitations are compensated by providing Adjusted EBITDA only as a supplement to GAAP net income (loss) and clearly identifying the difference between the two measures. Consequently, Adjusted EBITDA should not be considered in isolation or as a substitute for net income (loss) presented in accordance with GAAP. Adjusted EBITDA as defined by the Company may not be comparable with similarly named measures provided by other entities.

Safe Harbor Statement

Statements in this news release about Intellicheck's future expectations, including: the advantages of our products, future demand for Intellicheck's existing and future products, whether revenue and other financial metrics will improve in future periods, whether Intellicheck will be able to execute its turn-around plan or whether successful execution of the plan will result in increased revenues, whether sales of our products will continue at historic levels or increase, whether brand value and market awareness will grow, whether the Company can leverage existing partnerships or enter into new ones, and all other statements in this release, other than historical facts, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These statements, which express management's current views concerning future events, trends, contingencies or results, appear at various places in this website and use words like "anticipate," "assume," "believe," "continue," "estimate," "expect," "forecast," "future," "intend," "plan," "potential," "predict," "project," "strategy," "target" and similar terms, and future or conditional tense verbs like "could," "may," "might," "should," "will" and "would" are forward-looking statements within the meaning of the PSLRA. This statement is included for the express purpose of availing Intellicheck, Inc. of the protections of the safe harbor provisions of the PSLRA. It is important to note that actual results and ultimate corporate actions could differ materially from those in such forward-looking statements based on such factors as market acceptance of Intellicheck's products and the presently anticipated growth in the commercial adoption of the Company's products and services, changing levels of demand for Intellicheck's current and future products, Intellicheck's ability to reduce or maintain expenses while increasing sales, customer results achieved using our products in both the short and long term, success of future research and development activities, Intellicheck's ability to successfully manufacture, market and sell its products, Intellicheck's ability to manufacture its products in sufficient quantities to meet demand within required delivery time periods while meeting its quality control standards, any delays or difficulties in the Company's supply chain, the success of the Company's sales and marketing efforts coupled with the typically long sales and implementation cycle for its products, Intellicheck's ability to enforce its intellectual property rights, changes in laws and regulations applicable to the Company's products, the Company's continued ability to access government-provided data, the risks inherent in doing business with the government including audits and contract cancellations, liability resulting from any security breaches or product failure, and other risks detailed from time to time in Intellicheck's reports filed with the SEC. We do not assume any obligation to update the forward-looking information.

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy